Clinical Features of Chronic Obstructive Pulmonary Disease with High Fractional Exhaled Nitric Oxide |
Ahn, Seong
(Division of Pulmonology, Department of Internal Medicine, Chonnam National University Medical School)
Kim, Tae-Ok (Division of Pulmonology, Department of Internal Medicine, Chonnam National University Medical School) Chang, Jinsun (Division of Pulmonology, Department of Internal Medicine, Chonnam National University Medical School) Shin, Hong-Joon (Division of Pulmonology, Department of Internal Medicine, Chonnam National University Medical School) Kwon, Yong-Soo (Division of Pulmonology, Department of Internal Medicine, Chonnam National University Medical School) Lim, Sung-Chul (Division of Pulmonology, Department of Internal Medicine, Chonnam National University Medical School) Kim, Yu-Il (Division of Pulmonology, Department of Internal Medicine, Chonnam National University Medical School) |
1 | Menezes AM, Montes de Oca M, Perez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest 2014;145:297-304. DOI |
2 | Kauppi P, Kupiainen H, Lindqvist A, Tammilehto L, Kilpelainen M, Kinnula VL, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma 2011;48:279-85. DOI |
3 | Soler-Cataluna JJ, Cosio B, Izquierdo JL, Lopez-Campos JL, Marin JM, Aguero R, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol 2012;48:331-7. DOI |
4 | Matsunaga K, Hirano T, Akamatsu K, Koarai A, Sugiura H, Minakata Y, et al. Exhaled nitric oxide cutoff values for asthma diagnosis according to rhinitis and smoking status in Japanese subjects. Allergol Int 2011;60:331-7. DOI |
5 | Takayama Y, Ohnishi H, Ogasawara F, Oyama K, Kubota T, Yokoyama A. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap. Int J Chron Obstruct Pulmon Dis 2018;13:2525-32. DOI |
6 | Kim SH, Kim TH, Sohn JW, Yoon HJ, Shin DH, Park SS. Reference values and determinants of exhaled nitric oxide in healthy Korean adults. J Asthma 2010;47:563-7. DOI |
7 | Jo EJ, Song WJ, Kim TW, Park HW, Chang YS, Kim TB, et al. Reference ranges and determinant factors for exhaled nitric oxide in a healthy korean elderly population. Allergy Asthma Immunol Res 2014;6:504-10. DOI |
8 | Malinovschi A, Ludviksdottir D, Tufvesson E, Rolla G, Bjermer L, Alving K, et al. Application of nitric oxide measurements in clinical conditions beyond asthma. Eur Clin Respir J 2015;2:28517. DOI |
9 | Lu Z, Huang W, Wang L, Xu N, Ding Q, Cao C. Exhaled nitric oxide in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 2018;13:2695-705. DOI |
10 | Beeh KM, Kornmann O, Beier J, Ksoll M, Buhl R. Clinical application of a simple questionnaire for the differentiation of asthma and chronic obstructive pulmonary disease. Respir Med 2004;98:591-7. DOI |
11 | Hynes G, Brightling C, Bafadhel M. Fractional exhaled nitric oxide in chronic obstructive pulmonary disease. Eur Respir J 2015;46(Suppl 59):PA3993. |
12 | Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009;64:728-35. DOI |
13 | Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003;124:474-81. DOI |
14 | Belvisi MG, Stretton CD, Yacoub M, Barnes PJ. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharmacol 1992;210:221-2. DOI |
15 | Alving K, Janson C, Nordvall L. Performance of a new handheld device for exhaled nitric oxide measurement in adults and children. Respir Res 2006;7:67. DOI |
16 | Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184:602-15. DOI |
17 | Chen FJ, Huang XY, Liu YL, Lin GP, Xie CM. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD. Int J Chron Obstruct Pulmon Dis 2016;11:2385-90. DOI |
18 | Miskoff JA, Dewan A, Chaudhri M. Fractional exhaled nitric oxide testing: diagnostic utility in asthma, chronic obstructive pulmonary disease, or asthma-chronic obstructive pulmonary disease overlap syndrome. Cureus 2019;11:e4864. |
19 | Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38. DOI |
20 | Wang Z, Pianosi PT, Keogh KA, Zaiem F, Alsawas M, Alahdab F, et al. The diagnostic accuracy of fractional exhaled nitric oxide testing in asthma: a systematic review and meta-analyses. Mayo Clin Proc 2018;93:191-8. DOI |
21 | Jo YS, Choe J, Shin SH, Koo HK, Lee WY, Kim YI, et al. Exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease: clinical implications of the use of inhaled corticosteroids. Tuberc Respir Dis 2020;83:42-50. DOI |
22 | Feng JX, Lin Y, Lin J, He SS, Chen MF, Wu XM, et al. Relationship between fractional exhaled nitric oxide level and efficacy of inhaled corticosteroid in asthma-COPD overlap syndrome patients with different disease severity. J Korean Med Sci 2017;32:439-47. DOI |
23 | Sahal A, James K, Mitchell V, Das J, Mansur A. Correlation of fractional exhaled nitric oxide (FeNO) and peripheral blood eosinophils (PBE) in refractory asthma. Eur Respir J 2014;44:P1032. |
24 | Fu JJ, McDonald VM, Gibson PG, Simpson JL. Systemic inflammation in older adults with asthma-COPD overlap syndrome. Allergy Asthma Immunol Res 2014;6:316-24. DOI |
25 | Song WJ, Kwon JW, Kim EJ, Lee SM, Kim SH, Lee SY, et al. Clinical application of exhaled nitric oxide measurements in a korean population. Allergy Asthma Immunol Res 2015;7:3-13. DOI |
26 | Postma DS, Rabe KF. The asthma-COPD overlap syndrome. N Engl J Med 2015;373:1241-9. DOI |
27 | Shrestha SK, Drews A, Sharma L, Pant S, Shrestha S, Neopane A. Relationship between total serum immunoglobulin E levels, fractional exhaled breath nitric oxide levels and absolute blood eosinophil counts in atopic and non-atopic asthma: a controlled comparative study. J Breath Res 2018;12:026009. DOI |
28 | Gao J, Zhang M, Zhou L, Yang X, Wu H, Zhang J, et al. Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD. Int J Chron Obstruct Pulmon Dis 2017;12:1287-93. DOI |
29 | Brusselle G, Pavord ID, Landis S, Pascoe S, Lettis S, Morjaria N, et al. Blood eosinophil levels as a biomarker in COPD. Respir Med 2018;138:21-31. DOI |
30 | Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442. DOI |
31 | Global Initiative for Chronic Obstructive Lung Disease. The global strategy for the diagnosis, management and prevention of COPD [Internet]. Fontana, WI: Global Initiative for Chronic Obstructive Lung Disease; 2019 [cited 2019 Sep 2]. Available from: http://goldcopd.org. |
32 | Zeki AA, Schivo M, Chan A, Albertson TE, Louie S. The asthma-COPD overlap syndrome: a common clinical problem in the elderly. J Allergy (Cairo) 2011;2011:861926. DOI |
33 | Gibson PG, McDonald VM. Asthma-COPD overlap 2015: now we are six. Thorax 2015;70:683-91. DOI |
![]() |